AMI
In clinical practice,       patients with AMI, not included in current randomized trials comparing primary       angioplasty with thrombolysis, account for 22% of all patients with AMI treated       with one of those two therapies.
In clinical practice,        @OBJECT$   @PREDICAT$   @SUBJECT$ , not included in current randomized trials comparing primary       angioplasty with thrombolysis, account for 22% of all patients with AMI treated       with one of those two therapies.